Publications

Research and Publications by Dr. Mames

  1. Intermittent Coronary Sinus Occlusion Does Not Reduce Infarct Size or Ischernic Dysfunction in an Occlusion /Reperfusion Model. Diltz, E.A., Marnes, R.N., Lee, J.W., Underwood, R., Mishra, A., Vanheyningen, C.A., and Nicklas, J.M. Circulation. Vol. 72/111. pg. 1200. 1985.
  2. Central Retinal and Posterior Ciliary Artery Occlusion After Particle Embolization of the External Carotid Artery System. Marnes, R.N., Snady-McCoy, Lory, and Guy, J. Ophthalmology. Vol. 98/4. pgs. 527-531. 1991.
  3. Retinal Pigment Epithelial Tear Following Treatment of Metastatic Carcinoma of the Choroid. Marnes, R.N. and Margo C. Retina. Vol. 11 /4. pgs. 430-432.1991.
  4. Inadvertent Penetrating Injury to the Globe with Periocular Corticosteroid Injection. Jain, V., Marnes, R.N., McGorry, S., and Giles, C. Ophthalmic Surgery. Vol. 22/9. pgs. 508- 511. 1991.
  5. Eye Care Guidelines for Patients with Diabetes Mellitus. Grant, M.B. and Mames, R.N. The Journal of the Florida Medical Association, Inc. Vol. 78/11. pgs. 754-756. 1991.
  6. Acute Frosted Branch Angfitis. Hamed, L.M., Fang, E.N., Fanous, M.M., Mames, R.N., and Friedman, S.M. J. Pediatric Ophthalmology Strabismus. Vol. 29. pgs. 312-313. 1992.
  7. Distribution of the Posterior Ciliary Artery Revealed After Vascular Occlusions. A Case Report. Marnes, R.N., Friedman, S.M., and Brown, G.C. Retina, Vol. 12, pg. 367-369,1992.
  8. Insulin-Like Growth Factor I Acts as an Angiogenic Agent in Rabbit Cornea and Retina: comparative Studies with Basic Fibroblast Growth Factor. Grant, M.B., Marnes, R.N., Fitzgerald, C, Ellis, E.A., Friekha, M.A., and Guy, J. Diabetologia. Vol 36. pgs.282-291. 1993.
  9. Subretinal Hemorrhage After Grid Laser Photocoagulation for Idiopathic Juxtafoveolar Retinal Telangiectasis. Friedman, S.M., Marnes, R.N., and Stewart, M.W. Ophthalmic Surgery. Vol. 24. pgs. 551-553.1993.
  10. Perfluoroperhydrophenanthrene (Vitreon ®) as a Short-term Vitreous Substitute after Complex Vitreoretinal Surgery. Tanji, T.M., Peyman, G.A., Mehta, N.J., Millsap, C.M., Vitreon Study Group. Ophthalmic Surgery. Vol. 24. pgs. 681-685. November, 1993.
  11. Perfluoroperhydrophenanthrene (Vitreon) in the Management of Giant Retinal Tears: Results of a Collaborative Study. Millsap, C., Peyman, G., Mehta, N., Greve, M., Lee, K., Ma, P., Dunlap, W. Ophthalmic Surgery. Vol. 24. pgs. 759-763. November, 1993.
  12. Treatment of Diabetic Retinopathy: A View For the Internist - Commentary. Mames, R.N. and Grant, M.E. Abstracts of Clinical Care Guidelines. A Joint Commission Newsletter. Vol. 5. pgs. 8-9. 1993. Role of Hydrogen Peroxide in Experimental Optic Neuritis:
    A Serial Quantitative Ultrastructutral Study. Guy, J, Ellis, E.A., Mames, R., and Rao, A. N. Ophthalmic Research. Vol. 25. pgs. 253-264.1993.
  13. Acute Retinal Necrosis After Chickenpox in a Patient with AIDS. Friedman, S.M., Mames, R.N., Sleasman, JW., and Whitcup, S.M. Archives of Ophthalmology. Vol. 111. pgs. 1607-1608. December, 1993.
  14. Insulin-like Growth Factor I as an Angiogenic Agent. Grant, M.B., Mames, R.N., Fitzgerald,
    E.A., Ellis, E.A., Caballero, S., Chegini, N., and Guy, J. Ann. NY Academy Sci. Vol. 692. pgs. 230-242. 1993.
  15. Repair of Retinal Detachment Associated with Proliferative Vitreoretinopathy using
    Perfluoroperhydrophenanthrene (Vitreon ®). Carroll, B.F., Peyman, G.A., Mehta, N.J.,
    Millsap, C.M., Greve, M.D.J., Dunlap, W.A., Lee, K.J., Ma, P.E. Can J Ophthalmol. Vol. 29. pgs. 66-69. 1994.
  16. Diabetic Retinopathy: Background, Classification, Pathophysiology. Mames, R. Journal of
    the Florida Medical Association, Inc. Vol. 81/4. pgs. 240-242. April, 1994.
  17. Endogenous Klebsiella Endophthahnitis: Report of Two Cases and Review of the Literature.
    Margo, C.E., Mames, R.N., Guy, J.R. Ophthalmology. Vol. 101. pgs. 1298-1301. July, 1994.
  18. Experimental Vitreous Replacement with Perfluorotri-n-Propylamine. Bryan, J.S., Friedman,
    S.M., Mames, R.N., and Margo, C.E. Archives of Ophthalmology. Vol. 112. pgs. 1098-1102. August, 1994.
  19. Postoperative Chronic Pressure Abnormalities in the Vitreon® Study. Adile, S.L., Peyman,
    G.A., Greve, M.D.J., Millsap, C.M., Versa, L.K., Wafapoor, H., Soheilian, M. Ophthalmic
    Surgery, Vol. 25. pgs. 584-589,1994.
  20. Vitreon Collaborative Study Group: An Analysis of a Posterior Segment Complications after
    Vitrectomy Using the Perfluorocarbon Perfluoreoperhydrophenanthrene (Vitreon®). Verman, L.K., Peyman, G.A., Wafapoor, H., Greve, M.D.J., Millsap, C.M., Adile, S.L. Ophthalmic Surgery, Vol. 26. pgs. 29-33,1995.
  21. Peripheral Thrombolytic Therapy for Central Retinal Artery Occlusion. CRAO Study Group:
    Marries, R., Shugar, J., Levy, N., Brasington, A., Margo, C. Archives of Ophthalmology,
    September, 1995. Volume 113, pg. 1094.
  22. Peripheral Thrombolytic Therapy for Central Retinal Artery Occlusion. CRAO Study Group: Mames, R., Shugar, J., Levy, N., Brasington, A., Margo, C. Archives of Ophthalmology Edicion Espanola, Volumen 7, Numeo 1, pgs. 49-50. Enero-Febrero 1996.
  23. Diabetic Iris Neovascularization. Blinder, K., Friedman, S., and Mames, R. American Journal of Ophthalmology, September, 1995. Vol. 120, pgs. 393-395.
  24. Results of the Endophthalmitis Vitrectomy Study. Endophthalmitis Vitrectomy Study
    Group. Archives of Ophthalmology, Volume 113, pgs. 1479-1496. December, 1995.
  25. Microbiologic Factors and Visual Outcome in the Endophthalmitis Vitrectomy Study. The
    Endophthalmitis Vitrectomy Study Group. American Journal Ophthalmology, December 1996 Volume 133, Number 6, pgs. 830-846.
  26. Plasminogen Activator Inhibitor-1 Overexpression in Non-proliferative Diabetic
    Retinopathy. Grant, M.B., Caballero, S., Ellis, E.A., and Mames, R.N. Experimental Eye
    Research, 1996, Volume 63, pgs. 233-234.
  27. Surgical Management of Traumatic Retinal Detachment with Perfluorocarbon Liquid.
    Soheilian, M., Peyman, G.A., Thompson, H., Wafapoor, H., Navaro, J.C. for Vitreon Study
    Group International Ophthalmology, 1996, Volume 20, pgs. 241-249.
  28. An Investigation of the Hospital Charges Related to the Treatment of Endophthalmitis in
    the Endophthalmitis Vitrectomy Study. EVS Study Group. Ophthalmology, May, 1997,
    Volume 104, Number 5, pgs. 739-745.
  29. Evaluation of Microbiological Diagnostic Techniques in Postoperative Endophthalmitis in the
    Endophthalmitis Vitrectomy Study. EVS Study Group. Archives of Ophthalmology,
    September, 1997, Volume 115, pgs 1142-1150.
  30. Positive Vitreous Cultures from Eyes without Signs of Infectious Endophthalmitis. Mames
    R.N., Friedman, S.M., Stinson, W.G., Margo, C.M. Ophthalmic Surgery and Laser, 1997,
    Volume 28, Number 5, pgs. 365-369.
  31. Identification of Sclerotomy Sites for Posterior Segment Surgery in the Dog. Smith, P.J., Pennea, L., MacKay, E.O., and Marnes, R.N. Veterinary & Comparative Ophthalmology, 1997, Volume 7, Number 3, pgs. 180-189.

Abstarcts by Dr. Mames

  1. Capsule Formation After Explants and Implants: Histopathological Analysis. Mames, R., Tolentino, F., and Lahav M. Investigative Ophthalmology and Visual Science Supplement. Vol. 30/3. pg. 350. 1989.
  2. Periocular Steroid Injections with Globe Penetration. Weiss, H., Mames, R., Kozlow, D., and Giles, C. Investigative Ophthalmology and Visual Science Supplement. Vol. 30/3. pg. 509. 1989.
  3. Histochemical Localization of Hydrogen Peroxide in Retinopathy of Prematurity of the Neonatal Rabbit. Lorenzen, T., Ellis, E.A., Guy, J.G., Knight, M.E., Andresen, T.L. and Mames, R.N. Investigative Ophthalmology and Visual Science Supplement. Vol.31/4. pg. 119. 1990.
  4. Vascular Proliferation of the Retina Induced by Insulin-Like Growth Factor I (IGF I). Mames, R., llis, A., Friekha, M., Margo, C., Guay, C., and Grant, M.B. Investigative Ophthalmology and Visual Science. Vol. 32/4. pg. 754. 1991.
  5. Insulin-Like Growth Factor (IGF I) Induced Demyelination of the Optic Nerve. Ellis, E.A., Mames, R., Guay, C., Grant , M.B., and Guy, J. Investigative Ophthalmology and Visual Science. Vol. 32/4. pg. 857. 1991.
  6. Insulin-Like Growth Factor I (IGF I) Induces Retinal Vascular and Optic Nerve Pathology. Grant, M., Mames, R., Friekha, M., Margo, C., Guay, C., Ellis, A., and Guy, J. Endocrine Society. Vol. 482A . 1991.
  7. Basic Fibroblast Growth Factor Stimulates Fibrovascular Proliferation in Rabbit Retina. Mames, R.N., Ellis, E.A., Guy J.R., Margo, C.E., and Grant, M.B. Investigative Ophthalmology and Visual Science. Vol. 33/4. pg. 1088. 1992.
  8. Antioxidant Enzyme Reduction of H2O2 ?? and Blood-Optic Nerve Barrier Disruption in Experimental Optic Neuritis. Guy, J., Ellis, E. A., Fitzsimmons, J., Beck, B., Mames, R. Investigative Ophthalmology and Visual Science. Vol. 33/4. pg. 1185. 1992.
  9. Insulin-Like Growth Factor I (IGF I) and Basic Fibroblast Growth Factor (b-FGF) Stimulate Vascular Proliferation in Rabbit Retina. Grant, M.B., Mames, R., Ellis, A., Guy, J., Diabetes. Vol. 41 (Supplement 1.) pg. 18A. 1992.
  10. Culture Positivity in Vitrectomy: Observations and Implications for Endophthalmitis. Stinson, W.G., Mames, R.N., and Friedman S.M. Vitreous Society. October 18-21. 1992.
  11. Multi-Center Evaluation of Perfluoroperhydrohenantrene in the Management of Complex Vitreoretinal Surgery. Metha, N.J., Peyman, G.A., Alturki, W.A., and The Multi-Center Vitreon Study Group. Ophthalmology. Vol. 99/9A. pg. 148. 1992.
  12. Positive Cultures from Surgical Cassettes During Vitrectomy. Stinson, W.G., Mames, R.N., and Friedman, S.M. Investigative Ophthalmology and Visual Science. ARVO. Vol. 34/4 pg. 1259. 1993.
  13. Review of Treatment of Diabetic Retinopathy by P. Raskin and C. Arauz-Pacheco. Mames, R.N., and Grant, M.B. Abstracts of Clinical Care Guidelines 2:7-9, 1993.
  14. Photoreceptor Density Inversely Proportional To Axial Length. Schreiber, P., Mames, R., Maida, T., Guy, J., Lewis, P., and Brooks, D. Investigative Ophthalmology and Visual Science. ARVO. Vol. 35/4. pg. 1801. 1994.
  15. Increased Expression of Plasminogen Activator Inhibitor by Retinal Endothelial Cells and Ocular Tissue of Diabetic Origin. Grant, M. D., Caballero, S., Ellis, E.A., Hansen, B.C., and Mames, R.N. Investigative Ophthalmology and Visual Science. ARVO. Vol. 35/4.. pg. 1870. 1994.
  16. Increased Plasminogen Activator Inhibitor -1 (PAI-1) in a Rabbit Model of Retinopathy and in Human Diabetic Ocular tissue. Grant, M.B., Ellis, E.A., Caballero, S., and Mames, R.N. Diabetes 43(1):111A, 1994.
  17. Semi-quantitation of Angiogensis in a New Simple Model. Grant, M.B., Tyrrel, D.J., Ellis, E.A., Kugel, V., Rossing, M., Mames, R.N., Summers, B., and Galardy, R. Angiogensis Antagonists Conference, Cambridge Healthtech Institute, April 1995.
  18. Plasminogen Activator Inhibitor-1 (PAI-1) Over-expression in Diabetic Retinopathy and in Insulun-like Growth Factor 1 (IGF-1) Induced Retinopathy. Grant, M.B., Mames, R.N., Ellis, E.A., and Caballero, S. The Endocrine Society, June 1995, Vol. P3-195A, pg. 517.
  19. Insulin-Like Growth Factor I and Demyelination: Cytochemical Evidence for Free Radical Derived Oxidant Mediation. Ellis, E.A., Grant, M.B., and Mames R.N. Proc Microsc Soc Amer, August 1995, Vol. 53. pgs. 996-997.
  20. Octreotide Improves Diabetic Nephropathy, Neuropathy and Glycemic Control, but not Retinopathy. Grant, M,B., Mames, R.N., Caballero, S., and Fitzgerald, C. American Diabetes Association Annual Meeting, January, 1996, Diabetes, Volume 45 Issue 2 pg. 16A.
  21. Octreotide (OCT) Does Not Prevent Progression of Diabetic Retinopathy (DR). Grant, M.,
    Mames, R., Cooper, R., Caballero, S., Fitzgerald, C. ARVO. Volume 37 (3). pg. S958. Presented April, 1996.

Research and Publications by Dr. Hines

  1. Fish, R.H., Teeters, V.W., Hines, M.W. Surgical management of the acquired immune deficiency syndrome retinopathies. Ophthal Clin N Am., 7: 101-111, 1994.
  2. Hines, M.W., Jost, B.F., Fogelman, K.L.: Oculab tono-pen Goldmann applanation tonometry and pneumatic tonometry for intraocular pressure assessment in gas-filled eyes. Am Jour Ophthalmol 106: 174,1988.
  3. Engle, H.E., Dawson, W.W., Ulshafer, R.J., Hines, M.W., Kessler, M.D.: Degenerative changes in the maculas of rhesus monkeys. Ophthalmologica 196: 143, 1988.
  4. Hines, M.W., Guy, J.R.: Mechanism of visual loss in cavernous sinus thrombosis. Neurology 1986: 36 SuppI 1:248.
  5. Resident Coordinator of Ocular Trauma at the University of Florida, 1985 - 1987, as part of National Eye Trauma Study
  6. Co-Investigator of Pilot Project for Investigation of Age Related Macular Degeneration in Primates at the Caribbean Primate Research Center, San Juan, Puerto Rico 1986 - 1987
Print